Abstract
Drug addiction is a serious brain disorder with somatic, psychological, psychiatric, socio-economic and legal implications in the developed world. Illegal (e.g., psychostimulants, opioids, cannabinoids) and legal (alcohol, nicotine) drugs of abuse create a complex behavioral pattern composed of drug intake, withdrawal, seeking and relapse. One of the hallmarks of drugs that are abused by humans is that they have different mechanisms of action to increase dopamine (DA) neurotransmission within the mesolimbic circuitry of the brain and indirectly activate DA receptors. Among the DA receptors, D2 receptors are linked to drug abuse and addiction because their function has been proven to be correlated with drug reinforcement and relapses. The recognition that D2 receptors exist not only as homomers but also can form heteromers, such as with the adenosine (A)2A receptor, that are pharmacologically and functionally distinct from their constituent receptors, has significantly expanded the range of potential drug targets and provided new avenues for drug design in the search for novel drug addiction therapies. The aim of this review is to bring current focus on A2A receptors, their physiology and pharmacology in the central nervous system, and to discuss the therapeutic relevance of these receptors to drug addiction. We concentrate on the contribution of A2A receptors to the effects of different classes of drugs of abuse examined in preclinical behavioral experiments carried out with pharmacological and genetic tools. The consequences of chronic drug treatment on A2A receptor-assigned functions in preclinical studies are also presented. Finally, the neurochemical mechanism of the interaction between A2A receptors and drugs of abuse in the context of the heteromeric A2A-D2 receptor complex is discussed. Taken together, a significant amount of experimental analyses provide evidence that targeting A2A receptors may offer innovative translational strategies for combating drug addiction.
Keywords: Adenosine (A)2A receptors, A2A-D2 receptor interaction, licit and illicit drugs of abuse, behavioral effects, neurochemistry, striatum, psychological, psychiatric, socio-economic, cannabinoids
Current Medicinal Chemistry
Title: The Importance of the Adenosine A2A Receptor-Dopamine D2 Receptor Interaction in Drug Addiction
Volume: 19 Issue: 3
Author(s): M. Filip, M. Zaniewska, M. Frankowska, K. Wydra and K. Fuxe
Affiliation:
Keywords: Adenosine (A)2A receptors, A2A-D2 receptor interaction, licit and illicit drugs of abuse, behavioral effects, neurochemistry, striatum, psychological, psychiatric, socio-economic, cannabinoids
Abstract: Drug addiction is a serious brain disorder with somatic, psychological, psychiatric, socio-economic and legal implications in the developed world. Illegal (e.g., psychostimulants, opioids, cannabinoids) and legal (alcohol, nicotine) drugs of abuse create a complex behavioral pattern composed of drug intake, withdrawal, seeking and relapse. One of the hallmarks of drugs that are abused by humans is that they have different mechanisms of action to increase dopamine (DA) neurotransmission within the mesolimbic circuitry of the brain and indirectly activate DA receptors. Among the DA receptors, D2 receptors are linked to drug abuse and addiction because their function has been proven to be correlated with drug reinforcement and relapses. The recognition that D2 receptors exist not only as homomers but also can form heteromers, such as with the adenosine (A)2A receptor, that are pharmacologically and functionally distinct from their constituent receptors, has significantly expanded the range of potential drug targets and provided new avenues for drug design in the search for novel drug addiction therapies. The aim of this review is to bring current focus on A2A receptors, their physiology and pharmacology in the central nervous system, and to discuss the therapeutic relevance of these receptors to drug addiction. We concentrate on the contribution of A2A receptors to the effects of different classes of drugs of abuse examined in preclinical behavioral experiments carried out with pharmacological and genetic tools. The consequences of chronic drug treatment on A2A receptor-assigned functions in preclinical studies are also presented. Finally, the neurochemical mechanism of the interaction between A2A receptors and drugs of abuse in the context of the heteromeric A2A-D2 receptor complex is discussed. Taken together, a significant amount of experimental analyses provide evidence that targeting A2A receptors may offer innovative translational strategies for combating drug addiction.
Export Options
About this article
Cite this article as:
Filip M., Zaniewska M., Frankowska M., Wydra K. and Fuxe K., The Importance of the Adenosine A2A Receptor-Dopamine D2 Receptor Interaction in Drug Addiction, Current Medicinal Chemistry 2012; 19 (3) . https://dx.doi.org/10.2174/092986712803414231
DOI https://dx.doi.org/10.2174/092986712803414231 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hallucinations Associated with Topiramate Therapy: A Case Report and Review of the Literature
Current Drug Safety <i>Propionibacterium acnes</i> in the Pathogenesis and Immunotherapy of Acne Vulgaris
Current Drug Metabolism Medullary Thyroid Cancer: A Promising Model for Targeted Therapy
Current Molecular Medicine Meet Our Regional Editor
Current Bioinformatics Enantiomeric Resolution of Ibuprofen and Flurbiprofen in Human Plasma by SPE-Chiral HPLC Methods
Combinatorial Chemistry & High Throughput Screening Approaches to Stabilize Amorphous Form - A Review
Current Drug Therapy SNAP-tag based Agents for Preclinical In Vitro Imaging in Malignant Diseases
Current Pharmaceutical Design Alzheimer Disease Diagnosis from fMRI Images Based on Latent Low Rank Features and Support Vector Machine (SVM)
Current Signal Transduction Therapy Global HIV Prevention, Testing, and Counseling in Military Populations
Current HIV Research Recent Advances in Application of Poly-Epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-Tumor Drugs
Current Cancer Drug Targets CD24 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: Targeting Redundancy for Immunotherapy?
Current Immunology Reviews (Discontinued) The Plasma Membrane: A Target and Hurdle for the Development of Anti- A? Drugs?
Current Drug Targets - CNS & Neurological Disorders The NK-1 Receptor: A New Target in Cancer Therapy
Current Drug Targets Multi-Constituent Cardiovascular Pills (MCCP) - Challenges and Promises of Population-Based Prophylactic Drug Therapy for Prevention of Heart Attack
Current Pharmaceutical Design Inhibition of Efflux of Quinolines as New Therapeutic Strategy in Malaria
Current Topics in Medicinal Chemistry Antioxidant Properties of Nitric Oxide in Cellular Physiological and Pathophysiological Mechanisms. The Implications of Biological Balance between NO and Oxidative Stress
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Role of 5-HT3 Receptors in Drug Abuse and as a Target for Pharmacotherapy
CNS & Neurological Disorders - Drug Targets Association Analysis of the Tryptophan Hydroxylase 2 Gene Polymorphisms in Patients with Methamphetamine Dependence/Psychosis
Current Neuropharmacology Biological Basis of Ageing, Age-related Diseases and Interventions
Current Pharmacogenomics and Personalized Medicine Beneficial effect of minimal interference on item memory but not on source memory in Alzheimer's disease
Current Alzheimer Research